Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $0.52 M | -98.47% |
2023 | $34.46 M | 37.16% |
2022 | $25.12 M | -77.35% |
2021 | $0.11 B | -22.81% |
2020 | $0.14 B | 75.04% |
2019 | $82.12 M | 83.74% |
2018 | $44.69 M | 65.13% |
2017 | $27.06 M | 34.62% |
2016 | $20.1 M | -43.12% |
2015 | $35.35 M | 3933.77% |
2014 | $0.87 M | 1389.9% |
2013 | $0.05 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.12 B | $0.58 B | ๐บ๐ธ USA |
Abbott Laboratories ABT | $58.05 M | $0.14 B | ๐บ๐ธ USA |
AbbVie ABBV | $10.61 M | $0.22 B | ๐บ๐ธ USA |
Sanofi SNY | $25.9 M | $53.82 M | ๐ซ๐ท France |
Merck MRK | $26.86 M | $0.19 B | ๐บ๐ธ USA |
AstraZeneca AZN | $98.25 M | $0.17 B | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $12.4 M | $23.22 M | ๐ฌ๐ง UK |
Fortress Biotech
FBIO | N/A | $0.27 M | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $11.62 M | $44.39 M | ๐ฎ๐ฑ Israel |